Exclusive Interviews

In this Exclusive Interview transcript, Kathleen Wyne talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA about adult onset type 1 diabetes and its misdiagnosis, and how to determine whether a patient has type 1 or type 2 diabetes.

In this Exclusive Interview, Kathleen Wyne talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA about the importance of understanding that adults can be diagnosed with type 1 diabetes and the commonality of the misdiagnosis of the condition.

In part 1 of this Exclusive Interview, Kathleen Wyne talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA about the importance of understanding diabetes diagnosis — and misdiagnosis — in adults.

In part 2 of this Exclusive Interview, Kathleen Wyne talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA about proving type 1 in an adult who was previously misdiagnosed.

In part 3 of this Exclusive Interview, Kathleen Wyne talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA about the insufficiency of DKA as a method of diagnosing diabetes.

In part 4 of this Exclusive Interview, Kathleen Wyne talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA about the irrelevance of age when diagnosing diabetes and the protocol when screening for cardiovascular complications.

In part 5, the conclusion of this Exclusive Interview, Kathleen Wyne talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA about starting statins in adults with type 1.

In this Exclusive Interview transcript, Aaron Vinik discusses the role of the brain in diabetes, moving away from a glucose-centric view of diabetes, and the importance of looking at heart rate.

AARON I. VINIK, MD, PhD, FCP, MACP, FACE is a global leader in basic and clinical neuropathy. He, in essence, has defined the heterogeneity of neuropathy, established a need for a modular approach depending on the particular nerve fiber damaged, and pioneered immunotherapy for autoimmune neuropathies.  He was awarded a lifetime achievement award by EASD Neurodiab in 2011 for his contributions to the understanding of neuropathies. In 2016, he received the American College of Endocrinology (AACE) Distinction in Endocrinology Award in recognition of advancing the understanding of endocrinology through research and education.

In this Exclusive Interview, Aaron Vinik, Diabetes in Control board member, talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the current position on the protein INGAP and the work to stop the body's attack on beta cells, which hinders advancement in this research. He also shares on balancing the body's autonomic nervous system.